Inactive Instrument
Pressure BioSciences, Inc. Stock Nasdaq
Stocks
US74112E1091
Advanced Medical Equipment & Technology
OTC Markets Traded|
End-of-day quote
Nasdaq
|
||
| - USD | - |
|
| Market Cap | 143K 128K 119K 108K 205K 13.88M 205K 1.43M 562K 7.07M 538K 527K 22.7M | P/E 2022 |
-0.81x | P/E 2023 | -0.22x |
|---|---|---|---|---|---|
| Enterprise Value | 22.95M 20.5M 19.07M 17.34M 32.74M 2.22B 32.88M 229M 89.91M 1.13B 86.18M 84.29M 3.63B | EV / Sales 2022 |
21.1x | EV / Sales 2023 | 15.5x |
| Free-Float |
99.27% | Yield 2022 * |
-
| Yield 2023 | - |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 75 | 16/04/2004 | |
| Chief Tech/Sci/R&D Officer | 61 | 03/04/2006 | |
Edmund Ting
CTO | Chief Tech/Sci/R&D Officer | 72 | 24/04/2006 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 75 | 01/01/1992 | |
Jeffrey Peterson
CHM | Chairman | 70 | 08/08/2012 |
Michael Urdea
BRD | Director/Board Member | 73 | 08/02/2013 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.93% | +0.49% | +25.38% | +32.63% | 243B | |
| +1.08% | +2.69% | +8.57% | +0.50% | 155B | |
| +2.06% | +8.17% | -1.31% | +42.35% | 150B | |
| +1.64% | +0.31% | -55.21% | -20.58% | 61.93B | |
| +1.15% | +0.07% | +15.24% | +16.87% | 49.12B | |
| +2.30% | +3.38% | -17.09% | -19.05% | 48.78B | |
| +1.41% | +1.65% | +24.83% | +50.53% | 48.08B | |
| +3.96% | +8.34% | +3.33% | +38.46% | 47.95B | |
| +1.08% | +2.01% | +31.05% | +61.37% | 42.62B | |
| Average | +1.73% | +2.82% | +3.86% | +22.57% | 94.01B | |
| Weighted average by Cap. | +1.51% | +2.75% | +7.65% | +23.49% |
| 2022 | 2023 | |
|---|---|---|
| Net sales | 1.73M 1.54M 1.44M 1.31M 2.47M 167M 2.48M 17.29M 6.78M 85.33M 6.49M 6.35M 274M | 1.98M 1.77M 1.64M 1.49M 2.82M 191M 2.83M 19.78M 7.75M 97.59M 7.43M 7.26M 313M |
| Net income | -16.08M -14.36M -13.36M -12.15M -22.94M -1.56B -23.04M -161M -62.99M -793M -60.37M -59.05M -2.55B | -29.31M -26.18M -24.35M -22.15M -41.83M -2.84B -42.01M -293M -115M -1.45B -110M -108M -4.64B |
| Net Debt | 20.53M 18.33M 17.05M 15.51M 29.29M 1.99B 29.41M 205M 80.42M 1.01B 77.08M 75.39M 3.25B | 22.8M 20.37M 18.95M 17.23M 32.54M 2.21B 32.68M 228M 89.35M 1.13B 85.64M 83.76M 3.61B |
Employees
-
Select your edition
All financial news and data tailored to specific country editions
